BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28885429)

  • 1. Long-Acting Reversible Contraception Initiation With a 2- to 3-Week Compared With a 6-Week Postpartum Visit.
    Chen MJ; Hou MY; Hsia JK; Cansino CD; Melo J; Creinin MD
    Obstet Gynecol; 2017 Oct; 130(4):788-794. PubMed ID: 28885429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
    Eggebroten JL; Sanders JN; Turok DK
    Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period.
    Zerden ML; Tang JH; Stuart GS; Norton DR; Verbiest SB; Brody S
    Womens Health Issues; 2015; 25(6):616-21. PubMed ID: 26212318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an additional early visit to routine postpartum care on initiation of long-acting reversible contraception: A randomized trial.
    Bernard C; Wan L; Peipert JF; Madden T
    Contraception; 2018 Sep; 98(3):223-227. PubMed ID: 29778586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications after interval postpartum intrauterine device insertion.
    Ramos-Rivera M; Averbach S; Selvaduray P; Gibson A; Ngo LL
    Am J Obstet Gynecol; 2022 Jan; 226(1):95.e1-95.e8. PubMed ID: 34461075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provision of immediate postpartum contraception to women living with HIV in the Eastern Cape, South Africa; a cross-sectional analysis.
    Adeniyi OV; Ajayi AI; Somefun OD; Lambert JS
    Reprod Health; 2020 Dec; 17(1):194. PubMed ID: 33298097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost sharing, postpartum contraceptive use, and short interpregnancy interval rates among commercially insured women.
    Moniz MH; Peahl AF; Fendrick AM; Kolenic GE; Tilea A; Wetmore M; Dalton VK
    Am J Obstet Gynecol; 2021 Mar; 224(3):282.e1-282.e17. PubMed ID: 32898503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
    Tocce K; Sheeder J; Python J; Teal SB
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an educational script on postpartum contraceptive use: a randomized controlled trial.
    Tang JH; Dominik RC; Zerden ML; Verbiest SB; Brody SC; Stuart GS
    Contraception; 2014 Aug; 90(2):162-7. PubMed ID: 24833047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in contraception: new options for postpartum women.
    Taub RL; Jensen JT
    Expert Opin Pharmacother; 2017 May; 18(7):677-688. PubMed ID: 28375776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early initiation of postpartum contraception: does it decrease rapid repeat pregnancy in adolescents?
    Damle LF; Gohari AC; McEvoy AK; Desale SY; Gomez-Lobo V
    J Pediatr Adolesc Gynecol; 2015 Feb; 28(1):57-62. PubMed ID: 25555302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited Uptake of Planned Intrauterine Devices During the Postpartum Period.
    Salcedo J; Moniaga N; Harken T
    South Med J; 2015 Aug; 108(8):463-8. PubMed ID: 26280769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraception after medication abortion in the United States: results from a cluster randomized trial.
    Rocca CH; Goodman S; Grossman D; Cadwallader K; Thompson KMJ; Talmont E; Speidel JJ; Harper CC
    Am J Obstet Gynecol; 2018 Jan; 218(1):107.e1-107.e8. PubMed ID: 28986072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of immediate postpartum intrauterine contraception after vaginal birth within a public maternity setting: Health services research evaluation.
    Cooper M; McGeechan K; Glasier A; Coutts S; McGuire F; Harden J; Boydell N; Cameron ST
    Acta Obstet Gynecol Scand; 2020 May; 99(5):598-607. PubMed ID: 31837002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postpartum long-acting reversible contraceptive use among active-duty, female US Army soldiers.
    Eastin EF; Nelson DA; Shaw JG; Shaw KA; Kurina LM
    Am J Obstet Gynecol; 2023 Oct; 229(4):432.e1-432.e12. PubMed ID: 37460035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.